The social media team is probably on drugs. Posting every 2-3 weeks some mysterious pictures. Nobody cares about the face of skin cancer. Just tease the OTC product and say it will be available on DD.MM.YYYY. And its good because it prevents skin cancer and other stuff. That could go viral. They could say " a special formulation for tanning, skin cancer....".
CUV social media is a joke. This post are a waste of time. #shitpost
Never sold a share, just my opinion.

Dr Wally

Well-known member
What about a advertising campaign built exclusively around absolute “truth in advertising”? 😳

Maybe something along the lines of:

Hey you!!….. Yes you!! Light skinned peoples of the world listen up, your life long dream of obtaining the perfect natural skin cancer preventing skintan is about to become reality!

You’ve been lied to for way too long!!

There really IS such a thing as a 100% natural and completely SAFE tan!!

And there has been since the Fking 1980s!! 🤬😁

Talk to your doctor today!!

FTC pledge.

“When consumers see or hear an advertisement, whether it’s on the Internet, radio or television, or anywhere else, federal law says that ad must be truthful, not misleading, and, when appropriate, backed by scientific evidence.”


The FTC enforces these truth-in-advertising laws, and it applies the same standards no matter where an ad appears – in newspapers and magazines, online, in the mail, or on billboards or buses.”


“The FTC looks especially closely at advertising claims that can affect consumers’ health or their pocketbooks – claims about food, over-the-counter drugs, dietary supplements, alcohol, and tobacco and on conduct related to high-tech products and the Internet.”

Ok then!

The FTC also monitors and writes reports about ad industry practices regarding the marketing of alcohol and tobacco. During the recent coronavirus (COVID-19) pandemic, the FTC has been sending warning letters to companies that may be violating the FTC Act, to warn them that their conduct is likely unlawful and that they can face serious legal consequences.”

Right we definitely won’t be having to worry about any of that!

At Clinuvel we are big believers in the WOKE agenda. We strive for all sorts of equality and we’re especially fond of the BLM movement (for reasons that might be obvious to some🤓👍🏽) and we absolutely love the idea of this “truth in advertising” thingy.

What makes us completely different to our competitors is that we can actually guarantee to our tens millions/billions😬 of potential customers that our products truely work and are literally backed up with decades of safety and efficacy data.

Now there’s much much more to come but it’s been a really really
big secret for sometime now and our supreme leader PW would be extremely p1ssed if we were to let the big brown, inflammation free, AIS symptom free, neuro cognitive disorder free frog out of the bag before he got around to enlightened the world about it all so just be happy with super safe cancer preventing natural skin tanning for now ok!)
Last edited:


Well-known member
@FarmaZutical I think it’s going to be a while before Scenesse is approved in China. It’s not clear when the Named Patient Program (NPP) even began, and if I’m not mistaken the language in the recent PRs give rise to the impression it may not have even begun due to Covid considerations. If you give a year for the NPP, then 18 months at least for a possible fast track application we’d be looking at end of 2022 to mid 2023 at the earliest (I seriously hope I’m wrong about that).

I don’t think the NMPA operates much differently from their Western counterparts: cancer or terminal illness drugs get processed relatively quickly, other drugs grind their way through the regulatory system with similar time frames. Bureaucracy, a pain in the ass all nations can relate to.
Last edited:


Staff member
@macgyver I'm pessimistic too, but here's the thing... I'm pessimistic on everything. The only thing that's proven over and over is Clinuvel keeps secrets.

If they can hide the Chinese approval process, they will. And this path to monetization is cheap... it'll hardly make a dent in their hoard of cash.

Not to mention, WinHealth has a vested interest in this too, and is positioned well to execute.

You're an ace researcher, how about bone up on your Chinese and probe behind the China firewall. :)


Well-known member
@johnnytech Yes certainly, but I’m rubbish at hacking. Can you help a guy out?🙃

For myself, the secrecy surrounding the Chinese entry to market had previously led me (and I suspect some others) to think somehow things are moving along at a clip purely because we haven’t heard anything and that the Chinese regulatory process is something most here are not familiar with. After looking into it further, there’s nothing so far that leads me to believe Scenesse would be approved any quicker than what would occur in the West, that’s irrespective of whether Clinuvel has the best suited Chinese partner to aid it through to the end. There may be some regulatory shortcut that pares down the time taken to reach approval, but not so much as to be a very rapid approval when compared with Western approval times. Believe me, if there’s something I’ve missed and Clinuvel pulls off a quick approval I’ll be over the moon.
Last edited:

Johnny H

Well-known member
It's illegal for US based companies to bribe foreign governments. Does Australia have the same law? Asking for a friend.

CUV Quote (Yesterday's close)

Time: 4:10PM AEST
Price: 41.94
Volume: 264669